Genetic Signatures

Genetic Signatures Limited – Annual Report 2021 Analysis of Holdings Genetic Signatures Limited Analysis of Holdings as at 23 September 2021 Additional Informaton Required Under ASX Listing Rules The additional information required by the Australian Securities Exchange (ASX) and not shown elsewhere in this report is set out below. The information is current at 23 September 2021. Issued Capital As at 23 September 2021 the Company had 143,036,246 fully paid ordinary shares on issue. Distribution of Equity Securities Analysis of numbers of equity security holders for GSS fully paid ordinary shares by size of holding: Unmarketable parcel of shares "The number of indivdual shareholders holding less than a marketable parcel of shares was 274 (a total of 62,755 shares held by 274 shareholders)." 329 fully paid ordinary shares comprise a marketable parcel at GSS' closing share price of $1.52 on 23 September 2021. Holdings Ranges Holders Total Units % 1-1,000 602 311,070 0.220 1,001-5,000 734 2,120,932 1.480 5,001-10,000 308 2,481,678 1.730 10,001-100,000 461 16,237,125 11.350 100,001-9,999,999,999 100 121,885,441 85.210 Totals 2,205 143,036,246 100.000